Showing results (231-240 of 253) with videos related to
Sort By:
Pageof 26
Cancer|November 16, 2019
Platinum exposure and cause-specific mortality among patients with testicular cancerHarmke J Groot, Flora E van Leeuwen, Sjoukje Lubberts, et al.The Lancet. Oncology|June 5, 2018
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort studyBo Jan Noordman, Manon C W Spaander, Roelf Valkema, et al.Cancers|March 6, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOXCharlotte I Stroes, Sandor Schokker, Remco J Molenaar, et al.Urologic Oncology|July 19, 2020
Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational studyR W M Vernooij, R G H M Cremers, H Jansen, et al.BMC Medical Physics|August 2, 2008
NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial)Mark van Heijl, Jikke M T Omloo, Mark I van Berge Henegouwen, et al.British Journal of Cancer|October 10, 2018
Risk of diabetes after para-aortic radiation for testicular cancerHarmke J Groot, Jourik A Gietema, Berthe M P Aleman, et al.European Journal of Nutrition|December 7, 2011
Bias in protein and potassium intake collected with 24-h recalls (EPIC-Soft) is rather comparable across European populationsSandra P Crispim, Anouk Geelen, Jeanne H M de Vries, et al.Journal of Inherited Metabolic Disease|November 10, 2025
Screening Tool Improves Recognition of Movement Disorders by Internists and Paediatricians in Patients With Inherited Metabolic DiseasesEllen M Hulshof, Hugo P Lantinga, Gonnie Alkemade, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)Tom van den Ende, Nicolien C de Clercq, Mark I van Berge Henegouwen, et al.Acta Oncologica (Stockholm, Sweden)|April 23, 2020
A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancerJudith de Vos-Geelen, Frank J P Hoebers, Sandra M E Geurts, et al.Pageof 26